A drug already used in the treatment of severe asthma could help treat exacerbations in asthma and COPD, a UK trial has found ...

London scientists have created a “game-changing” new treatment for asthma attacks that can reduce the need for further ...

Benralizumab is what’s known as a monoclonal antibody, which replicates properties of a normal antibody produced by the ...

Researchers at King's College London have found a new treatment for asthma attacks, which could be a 'game-changer' for the patients.

The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung ...

Benralizumab is the first treatment for asthma attacks and chronic obstructive pulmonary disease (COPD) in 50 years. The drug, which is delivered by an injection, helps to treat flare-ups of the ...

The first new treatment for asthma attacks in 50 years may be a “game-changer”, researchers say. Offering patients an ...